Lyophilizable Stem Cell-Hybrid Liposome with Long-Term Stability and High Targeting Capacity

Adv Healthc Mater. 2024 Sep;13(22):e2400704. doi: 10.1002/adhm.202400704. Epub 2024 May 31.

Abstract

The hybridization of liposome with stem cell membranes is an emerging technology to prepare the nanovehicle with the capacity of disease-responsive targeting. However, the long-term storage of this hybrid liposome has received limited attention in the literature, which is essential for its potential applicability in the clinic. Therefore, the preservation of long-term activity of stem cell-hybrid liposome using freeze-drying is investigated in the present study. Mesenchymal stem cell-hybrid liposome is synthesized and its feasibility for freeze-drying under different conditions is examined. Results reveal that pre-freezing the hybrid liposome at -20 °C in Tris buffer solution (pH 7.4) containing 10% trehalose can well preserve the liposomal structure for at least three months. Notably, major membrane proteins on the hybrid liposome are protected in this formulation and CXCR4-associated targeting capacity is maintained both in vitro and in vivo. Consequently, the hybrid liposome stored for three months demonstrates a comparable tumor inhibition as the fresh-prepared one. The present study provides the first insights into the long-term storage of stem cell hybrid liposome using lyophilization, which may make an important step forward in enhancing the long-term stability of these promising biomimetic nanovehicle and ease the logistics and the freeze-storage in the potential clinical applications.

Keywords: biomimetic liposome; freeze‐storage; lyophilization; mesenchymal stem cells; targeting drug delivery.

MeSH terms

  • Animals
  • Freeze Drying*
  • Humans
  • Liposomes* / chemistry
  • Mesenchymal Stem Cells* / cytology
  • Mesenchymal Stem Cells* / metabolism
  • Mice
  • Receptors, CXCR4 / metabolism

Substances

  • Liposomes
  • Receptors, CXCR4